Xiaflex Injection for Peyronie’s Disease: Cost, Success Rate, Side Effects, Recovery Timeline, and Alternatives

Peyronie’s disease is one of those conditions many men quietly search for before they ever speak to a doctor. A bend in the penis, a painful erection, a hard lump under the skin, difficulty with sex, or fear that the curve may worsen can create real anxiety. For some men, the problem is mild and mainly cosmetic. For others, Peyronie’s disease affects sexual function, confidence, relationships, and mental well-being.

One treatment that often comes up during research is Xiaflex injection. Xiaflex is the brand name for collagenase clostridium histolyticum, an enzyme-based prescription medicine injected directly into the Peyronie’s plaque. It is best known as a nonsurgical treatment option for men with Peyronie’s disease who have a palpable plaque and a significant penile curvature. According to the prescribing information, Xiaflex is used for adult men with Peyronie’s disease who have a palpable plaque and curvature deformity of at least 30 degrees at the start of therapy.

However, Xiaflex is not suitable for every man with Peyronie’s disease. It can be expensive, treatment takes time, side effects are common, and rare but serious complications can occur. This article explains Xiaflex injection for Peyronie’s disease in a practical way, including cost, success rate, recovery timeline, side effects, risks, and alternatives.

Xiaflex injection is a prescription treatment that contains collagenase clostridium histolyticum. Collagenase is an enzyme that breaks down collagen. In Peyronie’s disease, the curve is often caused by a fibrous plaque in the tunica albuginea, the tough tissue layer involved in erections. This plaque can reduce flexibility in one area of the penis, causing the penis to bend during erection.

The goal of Xiaflex treatment is not simply to “dissolve a lump” overnight. The injection weakens and disrupts collagen in the plaque. The treatment is then combined with penile modeling, which means controlled stretching and straightening exercises performed by the urology specialist and continued carefully at home. The combination of injection plus modeling is what helps reduce curvature over time.

Xiaflex is not a general injection for all forms of penile pain, erectile dysfunction, or mild curvature. It is usually considered when the plaque can be felt and the curve is significant enough to affect function or cause distress.

A good candidate for Xiaflex injection is usually an adult man with Peyronie’s disease who has a palpable plaque and a penile curvature of at least 30 degrees. Many guidelines and clinical discussions focus on men with stable disease, curvature in a treatable range, and enough erectile function for intercourse, either naturally or with medication.

This matters because Peyronie’s disease can have an active phase and a stable phase. During the active phase, pain and curvature may still be changing. During the stable phase, pain is often less prominent and the curve has stopped changing for several months. Xiaflex is generally more useful when the curvature is stable enough to measure and treat.

Men with complex deformities, severe hourglass narrowing, hinge effect, heavy plaque calcification, or severe erectile dysfunction may not get the same benefit from Xiaflex. In those cases, a urologist may discuss surgery, penile traction therapy, vacuum erection devices, or other approaches.

Xiaflex should not be used if the Peyronie’s plaque to be treated involves the urethra, which is the tube through which urine passes. It should also not be used in someone with a history of hypersensitivity to Xiaflex or collagenase products.

The main mistake many patients make is thinking of Xiaflex as a single injection that straightens the penis. In reality, Xiaflex treatment is a structured program. Each treatment cycle includes office visits and at-home penile exercises.

The official Xiaflex patient information describes each treatment cycle as requiring three office visits and daily penile exercises for six weeks. A treatment course can include up to four treatment cycles, spaced approximately six weeks apart. In each cycle, the patient receives a first injection, then a second injection one to three days later, followed by in-office penile modeling one to three days after the second injection. At-home exercises continue during the six-week period after each cycle.

The modeling part is important. The doctor stretches and bends the penis in a controlled way opposite the direction of the curve. The patient is then taught gentle stretching and straightening activities to perform at home. These exercises should be done exactly as instructed. Aggressive bending, forceful manipulation, or sexual activity too early can increase the risk of injury.

Xiaflex can improve penile curvature, but expectations need to be realistic. It is not usually described as a treatment that makes the penis perfectly straight. Many men are looking for enough improvement to make intercourse easier, reduce embarrassment, and improve confidence.

In clinical trials, men receiving Xiaflex with penile modeling had better improvement in curvature and symptom bother compared with placebo. The official Xiaflex results page describes two clinical trials in which men received Xiaflex injections or placebo injections along with penile stretching and straightening activities. The reported average treatment difference in erectile curvature was 17 percent in one study and 11 percent in another study compared with placebo at week 52.

Other published discussions of the IMPRESS trials often describe an average curvature improvement of about 34 percent in treated men, compared with about 18 percent in the placebo group. This is why a patient should not interpret “success” as complete correction. A man with a 60-degree curve, for example, may still have a bend after treatment, but even a moderate reduction may make intercourse more comfortable or possible.

The success rate also depends on the starting curvature, plaque characteristics, location of the bend, whether the condition is stable, and whether the patient completes the modeling exercises properly. Some men respond after fewer cycles; others may need the full course. Some do not respond enough and later choose surgery.

The cost of Xiaflex injection for Peyronie’s disease can be confusing because the patient may face several different charges. These may include the drug cost, urology consultation fees, injection administration fees, follow-up visits, penile modeling visits, imaging if required, and insurance-related costs.

In the United States, public drug price guides often list Xiaflex as a high-cost medication. Drugs.com listed Xiaflex 0.9 milligram injectable powder for injection from around $7,503 for one vial, although real-world costs can vary and price guides are not a guarantee of what a patient will pay.

The official Xiaflex cost support page states that about 94 percent of eligible commercially insured patients should pay zero dollars out of pocket for Xiaflex through the copay assistance program, based on historical claims analysis. However, this does not automatically mean treatment is free. The program has restrictions, may not apply to government insurance programs, and may cover the dose of Xiaflex but not necessarily office visit charges, administration costs, or other medical costs.

For patients without insurance, with limited coverage, or outside the United States, the cost may be very different. In many countries, Xiaflex availability may be limited or treatment may not be routinely offered. Because of this, anyone considering Xiaflex should ask the urology clinic for a written estimate that separates the medication cost from procedure fees and follow-up charges.

Good questions to ask include: How many vials may be needed? How many cycles are planned? Does insurance require prior authorization? Are office procedure fees separate? Is penile modeling billed separately? What happens financially if treatment is stopped after one or two cycles?

Side effects after Xiaflex injection are common because the injection is given directly into sensitive penile tissue. Many men experience bruising, swelling, tenderness, pain, or a small collection of blood under the skin near the injection area. These effects are often expected after treatment, but they should still be monitored.

The official Xiaflex safety information lists common side effects for Peyronie’s disease treatment, including penile hematoma, swelling at the injection site or along the penis, pain or tenderness, penile bruising, itching of the penis or scrotum, painful erection, erectile dysfunction, skin color changes, blisters, pain with sex, and a lump at the injection site.

Some bruising can look dramatic, which can frighten patients. Still, not every bruise means a serious complication. The key is knowing which symptoms are expected and which require urgent medical attention.

The most serious risk of Xiaflex injection for Peyronie’s disease is corporal rupture, commonly called penile fracture. This means one of the erectile chambers of the penis tears, usually during an erection. This can be a medical emergency and may require surgery.

The official Xiaflex safety information warns patients to contact a doctor immediately if they experience a popping sound or sensation in an erect penis, sudden loss of the ability to maintain an erection, penile pain, purple bruising and swelling, difficulty urinating, or blood in the urine. Serious hematoma, skin and soft tissue injury, allergic reaction, back pain reaction, and fainting are also described in the prescribing and safety information.

Because of the risk of corporal rupture or other serious penile injury, Xiaflex for Peyronie’s disease is available in the United States only through a restricted Risk Evaluation and Mitigation Strategy program. This means the injection should be administered by a trained healthcare provider who understands the correct technique and safety precautions.

Men should be especially careful about sexual activity after Xiaflex. The official patient guidance says not to have sex or any other sexual activity between the first and second injections of a treatment cycle, and not to have sex for at least four weeks after the second injection and until pain and swelling have resolved.

Recovery after Xiaflex is not the same for everyone, but the general timeline is fairly structured.

After the injection, the penis may be wrapped with a dressing. The urology team will explain when to remove it. Mild to moderate pain, tenderness, swelling, and bruising can occur. Patients should avoid unnecessary strain and follow activity instructions carefully.

During the first few days, bruising and swelling may increase before improving. The second injection is usually given one to three days after the first injection in the same treatment cycle. The patient should avoid sex and sexual activity during this time.

One to three days after the second injection, the urology specialist usually performs penile modeling in the office. This can be uncomfortable, but it is part of the treatment process. The doctor will also teach the patient how to perform gentle home exercises.

For about six weeks after each treatment cycle, the patient performs at-home penile modeling exercises as instructed. This phase is important for treatment success. Sexual activity should be avoided for at least four weeks after the second injection and until pain and swelling have gone away.

A full Xiaflex course may include up to four cycles, each about six weeks apart. This means the total treatment process may take around 24 weeks if all four cycles are completed. Some men stop earlier if the curvature improves enough, if the curve becomes less than 15 degrees, if side effects are concerning, or if the doctor decides further treatment is not clinically needed.

Many men search online for Xiaflex before and after photos. These images can be useful, but they can also create unrealistic expectations. Results vary widely. A man with a simple upward curve and a non-calcified plaque may respond differently from someone with hourglass narrowing, multiple plaques, severe indentation, or erectile dysfunction.

The best “before and after” comparison is usually done by the urologist through proper measurement of curvature during erection. Self-estimation can be inaccurate. A patient may feel he has improved because sex is easier, even if the measured degree change is modest. Another patient may have a measurable improvement but still feel dissatisfied if the remaining curve interferes with intercourse.

Success should be measured by function, comfort, sexual confidence, patient bother, and safety—not just by whether the penis appears completely straight.

Xiaflex is attractive because it is nonsurgical, office-based, and does not involve cutting or grafting. However, surgery may be more appropriate for some men, especially those with severe curvature, stable disease, complex deformity, significant indentation, or poor response to injections.

Common surgical options include penile plication, plaque incision or excision with grafting, and penile prosthesis placement in men with significant erectile dysfunction. Surgery can often provide a more dramatic correction, but it also carries risks such as penile shortening, changes in sensation, erectile dysfunction, recurrence, and surgical complications.

Xiaflex may be a reasonable option for a man who wants to avoid surgery and has a curvature pattern likely to respond. Surgery may be preferred when the deformity is severe, when intercourse is impossible, when erectile dysfunction is significant, or when the patient wants the most definitive correction after the disease has stabilized.

Penile traction therapy uses a mechanical device to apply gentle, sustained stretching over time. It may help reduce curvature and preserve or improve length in selected men. It requires patience and daily use. It may also be used along with other treatments, although patients should only combine treatments under medical supervision.

Vacuum erection devices may help some men with erectile function and tissue stretching, but they are not a direct replacement for Xiaflex. Importantly, the official Xiaflex safety information advises patients not to use a vacuum erection device during Xiaflex treatment unless their doctor specifically says it is safe.

Verapamil injections are sometimes used as an off-label treatment for Peyronie’s disease. Evidence is mixed, and results are generally considered less predictable than Xiaflex. Some doctors may consider it when Xiaflex is not available or not affordable.

Interferon alpha-2b is another injectable treatment discussed in urology guidelines. It may reduce curvature and plaque-related symptoms in selected patients, but availability, cost, side effects, and physician experience can limit its use.

In the early painful phase of Peyronie’s disease, pain may improve over time even without curvature correction. Some men with mild curvature and no sexual difficulty may choose observation, reassurance, and pain control rather than immediate procedural treatment.

Surgery remains an important option for stable Peyronie’s disease when deformity prevents intercourse, when the curve is severe, or when less invasive treatments are unlikely to help. The best surgical choice depends on curvature severity, penile length, erectile function, and deformity type.

Xiaflex may be worth considering if the curvature is causing distress or sexual difficulty, the plaque can be felt, the curvature is at least 30 degrees, erectile function is adequate, and the patient understands the time commitment, cost, and risks. It may not be worth it for men expecting instant or perfect straightening, men with very mild curvature, men who cannot follow sexual activity restrictions, or men whose anatomy makes injection treatment less suitable.

The decision should be made with a urologist experienced in Peyronie’s disease. A good consultation should include curvature measurement, plaque assessment, discussion of erectile function, review of photographs if appropriate, cost counseling, and a realistic explanation of outcomes.

Before agreeing to Xiaflex injection, a patient should ask the urologist:

• How many degrees is my curvature?
• Is my Peyronie’s disease stable or still changing?
• Can you feel the plaque clearly?
• Is the plaque calcified?
• Do I have hourglass deformity or hinge effect?
• Am I a good candidate for Xiaflex, surgery, traction therapy, or observation?
• How many cycles do you expect I will need?
• What will my out-of-pocket cost be?
• What side effects should I expect?
• What symptoms should make me call urgently?
• When can I safely resume sexual activity?
• How many Xiaflex cases have you treated?

These questions help patients move from fear-based decision-making to informed decision-making.

Xiaflex injection for Peyronie’s disease is a legitimate nonsurgical treatment option for selected men, but it is not a casual injection or a guaranteed cure. It works best when the diagnosis is clear, the plaque and curvature fit the approved treatment profile, the urologist is experienced, and the patient follows the modeling and activity instructions carefully.

For some men, Xiaflex can reduce curvature enough to improve sexual function and confidence. For others, the improvement may be modest, the cost may be difficult, or surgery may eventually be the better solution. The most important step is not to suffer silently or rely only on online photos and forums. A proper urology evaluation can clarify whether Xiaflex, traction therapy, observation, or surgery is the most sensible next step.

References: